Treatment of Ménière's disease by low-dosage intratympanic gentamicin application: Effect on otolith function

Laryngoscope

Volumn 117, Issue 12, 2007, Pages 2244-2250

  Helling, Kai ^a   Schönfeld, Uwe ^b   Clarke, Andrew H ^b  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Gentamicin; M ni re's disease; Saccule; Subjective visual vertical; Unilateral centrifugation; Utricle; Vestibular evoked myogenic potentials

Indexed keywords

GENTAMICIN;

ADULT; AGED; ARTICLE; CENTRIFUGATION; CLINICAL ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; EARDRUM; FEMALE; HUMAN; LOCAL ANESTHESIA; LOW DRUG DOSE; MALE; MENIERE DISEASE; OTOLITH; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEMICIRCULAR CANAL; TREATMENT DURATION; VESTIBULAR EVOKED MYOGENIC POTENTIAL;

ADMINISTRATION, TOPICAL; ADULT; AGED; ANTI-BACTERIAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROMYOGRAPHY; EVOKED POTENTIALS, AUDITORY; FEMALE; FOLLOW-UP STUDIES; GENTAMICINS; HUMANS; MALE; MENIERE DISEASE; OTOLITHIC MEMBRANE; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TYMPANIC MEMBRANE;

EID: 40349108744     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLG.0b013e3181453a3c     Document Type: Article

References (24)

1. Lange G, Maurer J, Mann W. Long-term results after interval therapy with intratympanic gentamicin for Ménière's disease. Laryngoscope 2004;114:102-105.
2. Cohen-Kerem R, Kisilevsky V, Einarson TR, Kozer E, Koren G, Rutka JA. Intratympanic gentamicin for Ménière's disease: a meta-analysis. Laryngoscope 2004;114:2085-2091.
3. Cruz RM, Lambert PR, Rubel EW. Light microscopic evidence of hair cell regeneration after gentamicin toxicity in chick cochlea. Arch Otolaryngol Head Neck Surg 1987;113:1058-1062.
4. Park JC, Cohen GM. Vestibular ototoxicity in the chick: effects of streptomycin on equilibrium and on ampullary dark cells. Am J Otolaryngol 1982;3:117-127.
5. Kimura RS, Iverson NA, Southard RE. Selective lesions of the vestibular labyrinth. Ann Otol Rhinol Laryngol 1988;97:577-584.
6. Odkvist LM, Noaksson L, Olsson S, Ledin T. Subjective visual horizontal determination during otolith stimulation by eccentric rotation in conservatively treated Ménière's disease. Int Tinnitus J 1998;4:75-77.
7. de Waele C, Tran Ba Huy P, Diard JP, Freyss G, Vidal PP. Saccular dysfunction in Ménière's patients. A vestibular-evoked myogenic potential study. Ann N Y Acad Sci 1999;871:392-397.
8. de Waele C, Meguenni R, Freyss G, Zamith F, Bellalimat N, Vidal PP, Tran Ba Huy P. Intratympanic gentamicin injections for Ménière disease: vestibular hair cell impairment and regeneration. Neurology 2002;59:1442-1444.
9. Rauch SD, Silveira MB, Zhou G, et al. Vestibular evoked myogenic potentials versus vestibular test battery in patients with Méniè re's disease. Otol Neurotol 2004;25:981-986.
10. Park HJ, Migliaccio AA, Della Santina CC, Minor LB, Carey JP. Search-coil head-thrust and caloric tests in Ménière's disease. Acta Otolaryngol 2005;125:852-857.
11. Perez N, Rama-Lopez J. Vestibular function at the end of intratympanic gentamicin treatment of patients with Ménière's disease. J Vestib Res 2005;15:49-58.
12. Picciotti PM, Fiorita A, Di Nardo W, Quaranta N, Paludetti G, Maurizi M. VEMPs and dynamic posturography after intratympanic gentamycin in Ménière's disease. J Vestib Res 2005;15:161-168.
13. Welgampola MS, Colebatch JG. Characteristics and clinical applications of vestibular-evoked myogenic potentials. Neurology 2005;64:1682-1688.
14. Wetzig J, Reiser M, Martin E, Bregenzer N, Baumgarten RJ. Unilateral centrifugation of the otoliths as a new method to determine bilateral asymmetries of the otolith apparatus in man. Acta Astronautica 1990;21:519-525.
15. Clarke AH, Schönfeld U, Hamann C, Scherer H. Measuring unilateral otolith function via the otolith-ocular response and the subjective visual vertical. Acta Otolaryngol (Stockh) 2001;545(Suppl):84-87.
16. Clarke AH, Schönfeld U, Helling K. Unilateral examination of utricle and saccule function. J Vest Res 2003;13:215-225.
17. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Ménière's disease. American Academy of Otolaryngology-Head Neck Surgery. Otolarngol Head Neck Surg 1995;113:181-185.
18. Scherer H. Provoked vestibular nystagmus and caloric reactions after sudden loss of vestibular function. Adv Otorhinolaryngol 1981;27:168-175.
19. Carey JP, Minor LB, Peng GC, Della Santina CC, Cremer PD, Haslwanter T. Changes in the three-dimensional angular vestibulo-ocular reflex following intratympanic gentamicin for Ménière's disease. J Assoc Res Otolaryngol 2002;3:430-443.
20. Takai Y, Murofushi T, Ushio M, Iwasaki S. Recovery of subjective visual horizontal after unilateral vestibular deafferentation by intratympanic instillation of gentamicin. J Vestib Res 2006;16:69-73.
21. Chia SH, Gamst AC, Anderson JP, Harris JP. Intratympanic gentamicin therapy for Meniere's disease: a meta-analysis. Otol Neurotol 2004;25:544-552.
22. Aran JM, Chappert C, Dulon D, Erre JP, Aurousseau C. Uptake of amikacin by hair cells of the guinea pig cochlea and vestibule and ototoxicity: comparison with gentamicin. Hear Res 1995;82:179-183.
23. Hoffer M, Allen K, Kopke RD, Weisskopf P, Gottshall K, Wester D. Transtympanic versus sustained-release administration of gentamicin: kinetics, morphology, and function. Laryngoscope 2001;111:1343-1357.
24. Pender DJ. Gentamicin tympanoclysis: effects on the vestibular secretory cells. Am J Otolaryngol 1985;6:358-367.